BioCentury
ARTICLE | Financial News

CancerVax raises $30 million

March 6, 2001 8:00 AM UTC

CancerVax (Carlsbad, Calif.), which is in Phase III testing of its allogeneic melanoma vaccine, raised $30 million in a private round. Investors included Forward Ventures; Vector Fund Management; Amer...